THORNTON JOSEPH CLAY (Interim CFO) received a stock award from CLOVER HEALTH INVESTMENTS, CORP. /DE
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/13/2026ACC: 0001801170-26-000202
Officer· Interim CFO
Since Mar 2026
+54.35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
54.35K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+54.35K
Price / share
—
Trade value
—
% of position
4.5%
8/12/2026
1.21M→1.27M
Total
Net shares
+54.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/12/2026 | A · Award | +54.35K | — | — | 4.5% | 1.21M | 1.27M |
| Total | +54.35K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported